Search - tctmd.com

Displaying 881 - 900 of 3565

Sort: Relevancy | Date

Presentation TCT 2015

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro

October 13, 2015

Presentation TCT 2015

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

Presenter: Jeffrey J. Popma, Mathew Williams

October 13, 2015

Presentation TCT 2015

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

Presenter: Michael J. Reardon, Torsten P. Vahl, Yingqiang Guo

October 13, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Melissa Daubert

October 13, 2015

Presentation TCT 2015

TCT 94: Balloon Postdilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis Procedural Results and In-Hospital Outcomes From 3,532 Patients in the CoreValve US Pivotal and Continued Access Trials

Presenter: Jeffrey J. Popma, Mathew Williams, J. Kevin Harrison

October 13, 2015

Presentation TCT 2015

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Moritz Seiffert

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

Presenter: Jeffrey J. Popma, Mathew Williams, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Presentation TCT 2015

TCT 91: Comparison of Portico and CoreValve Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Jeffrey J. Popma, Mathew Williams, Sami Alnasser

October 13, 2015

Presentation TCT 2015

Aortic Valve Patho-Biology: Anatomical Implications for TAVR Performance

Presenter: Raj Makkar, Michael J. Reardon, James M. McCabe

October 13, 2015

Presentation TCT 2015

The Human Aortic Valve: Technical Landmarks and Considerations for TAVR Implantation

Presenter: Raj Makkar, Michael J. Reardon, James M. McCabe

October 13, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2015

Special Lecture: Systematic Review on Management Strategies for Asymptomatic Severe AS

Presenter: D. Craig Miller, Alec S. Vahanian, Philippe Généreux

October 12, 2015

Advertisement

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

TCT 94: Balloon Postdilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis Procedural Results and In-Hospital Outcomes From 3,532 Patients in the CoreValve US Pivotal and Continued Access Trials

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 92: Transcatheter Aortic Valve Replacement in Asian Pacific Countries

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

TCT 91: Comparison of Portico and CoreValve Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis Insights From the Valve-in-Valve International Data (VIVID) Registry

Aortic Valve Patho-Biology: Anatomical Implications for TAVR Performance

The Human Aortic Valve: Technical Landmarks and Considerations for TAVR Implantation

Updates to CoreValve Extreme Risk Study Encouraging

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Special Lecture: Systematic Review on Management Strategies for Asymptomatic Severe AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content